Biopharma Credit Investments V (Master) Lp
Private Equity Fund · Cayman Islands · master fund
Advised by Pharmakon Advisors, Lp · reported Apr 2024
Gross asset value
$1.8B
Beneficial owners
163
Minimum investment
$0
Adviser & related persons own
1%
Structure & investors
- SEC fund ID
- 805-2616755366
- Exclusion
- 3(c)(7)
- Fund of funds
- No
- Owned by funds of funds
- 7%
- Non-US ownership
- 70%
- Adviser's clients invested
- 0%
Reported by the adviser in Form ADV Section 7.B.(1), filing of April 2024. Figures are as reported by the adviser and not independently verified.